6 results match your criteria: "N. Bekhtereva Institute of the Human Brain[Affiliation]"
[Attention deficit hyperactivity disorder in children and adolescents: lessons from the COVID-19 pandemic].
Zh Nevrol Psikhiatr Im S S Korsakova
January 2024
N. Bekhtereva Institute of the Human BraIn Russian Academy of Sciences, St. Petersburg, Russia.
Article Synopsis
- The lockdown during the COVID-19 pandemic caused significant disruptions in the daily routines of children and adolescents with ADHD, impacting their physical activity and increasing screen time.
- The review highlights the link between social restrictions and behavioral issues in this group, emphasizing how parental behavior can affect ADHD symptoms during isolation.
- Despite the pandemic's end, the isolation's effects may lead to long-term mental health challenges, necessitating targeted treatment approaches for affected children and adolescents.
[The relationship between visual dysfunction and cognitive deficit in schizophrenia].
Zh Nevrol Psikhiatr Im S S Korsakova
September 2021
Bekhterev National Research Medical Centre for Psychiatry and Neurology, St. Petersburg, Russia.
Objective: To investigate whether visual processing abnormalities are the result of visual dysfunction involving cognitive impairment or independent abnormalities and to identify the relationship of visual impairments with cognitive functions and severity of psychopathological symptoms.
Material And Methods: We compared results of visual size perception and actions on objects (motor assessment) in patients with schizophrenia (=37), including patients with non-resistant schizophrenia (=19) and healthy individuals (=20). Cognitive impairments were assessed with BACS.
[Efficacy and safety of Kinezia (fampridine) in the complex therapy of multiple sclerosis].
Zh Nevrol Psikhiatr Im S S Korsakova
December 2020
Pirogov Russian National Research Medical University, Moscow, Russia.
Objective: To analyze the efficacy and safety of fampridine** (Valenta Pharm, Russia) in the complex therapy of multiple sclerosis (MS).
Material And Methods: One hundred and twenty-six patients with MS were double blind randomized to receive fampridine (=60) or placebo (=66). Fampridine was administered in prolonged-release form (film-coated tablets, 10 mg) at a dose of 10 mg (1 tablet) 2 times a day, for 24 weeks.
[Cerebral metabolism in patients with cognitive disorders: a combined MRS and PET study].
Zh Nevrol Psikhiatr Im S S Korsakova
June 2019
N. Bekhtereva Institute of the Human Brain, Russian Academy of Sciences, St.-Petersburg, Russia.
Aim: Magnetic resonance spectroscopy (MRS) allows studying the content of many metabolites in neural tissue in vivo. There are numerous studies devoted to the MRS data analysis in Alzheimer's disease (AD), but their results are contradictory. Thus, it is rational to compare the data obtained with MRS and positron emission tomography (PET) with fluorodeoxyglucose (FDG), which allows evaluating the brain functional state.
View Article and Find Full Text PDF[Clinical manifestations of burnout].
Zh Nevrol Psikhiatr Im S S Korsakova
June 2019
N. Bekhtereva Institute of the Human Brain Russian Academy of Sciences, St.-Petersburg, Russia.
Aim: To study clinical manifestations of burnout.
Material And Methods: The study included 131 patients (38 men and 93 women) aged from 25 to 45 years. The control group consisted of 106 age-matched healthy people.
[Characteristics of cerebral glucose metabolism in patients with cognitive impairment in Parkinson's disease].
Zh Nevrol Psikhiatr Im S S Korsakova
November 2018
N. Bekhtereva Institute of the Human Brain of the Russian Academy of Science, St. Petersburg, Russia.
Aim: To study the relationship between early cognitive impairment symptoms and cerebral glucose metabolism in different brain regions (according to the positron emission tomography (PET) data) in Parkinson's disease (PD) in order to increase the diagnostic and treatment efficacy.
Material And Methods: Two groups of patients with PD (stage I-III), including 11 patients without cognitive disorders and 13 with mild cognitive impairment (MCI), were examined. The control group included 10 age-matched people with normal cognition.